Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Children’s Hospital Boston researchers regenerate zebrafish heart muscle

13.12.2002


Work has implications for repairing human heart muscle after heart attacks



Experiments on zebrafish provide important clues that could eventually lead to the ability to regenerate damaged human heart muscle, say researchers from the Howard Hughes Medical Institute at Children’s Hospital Boston. Reporting in the Dec. 13 issue of Science, a team led by HHMI investigator Mark T. Keating, MD, senior associate, department of Cardiology, showed for the first time that zebrafish can regenerate heart muscle within two months after a severe injury. The team also identified a possible genetic and molecular model for regeneration in zebrafish that could help direct further research in humans. The findings, while still in an early stage, might someday benefit millions of people who suffer heart attacks or experience other forms of cardiac injury.

The zebrafish is the subject of active study because of its ability to regenerate spinal cord, retina, and fins. This finding points to the study of zebrafish heart regeneration as a means to understand and reduce cardiac injury in humans. When a human heart is injured, it cannot "grow back" the damaged muscle, which is instead replaced by scar tissue. Too much scarring can impair the heart’s ability to pump and can lead to life-threatening arrhythmias. Keating and his colleagues believe that zebrafish, unlike humans, have especially vigorous development of new heart-muscle cells, or cardiomyocytes. This proliferation of cells regenerates the heart muscle with little or no scarring.


"We think that there’s a balance between scar formation and regeneration -- if you regenerate, you don’t scar, but if you can’t regenerate, you scar," Keating said. "If you inhibit cell proliferation in the zebrafish, the heart doesn’t regenerate and instead scars, like in humans. The implication, which isn’t proven, but is quite exciting, is that by enhancing human cardiomyocyte proliferation after heart injury, one may be able to enhance cardiac regeneration and reduce cardiac scarring."

In the experiments, Keating and co-authors Kenneth D. Poss and Lindsay G. Wilson, also of HHMI and Children’s Hospital Boston, injured the hearts of adult zebrafish by surgically removing 20 percent of the muscle from the heart’s lower chamber, or ventricle. They then returned the animals to water (most survived and resumed swimming) and examined their hearts at regular intervals. They compared their observations with those of a control group of zebrafish that had their hearts removed and returned to their bodies uninjured.

Within a week, the zebrafish with heart injuries were as active and swam as well as the zebrafish whose hearts were uninjured. Within two months, most injured ventricles had regained their size and shape and appeared to be contracting normally. Digitally aided measurements of the ventricles’ surface area showed complete recovery of heart muscle. Cardiomyocytes rapidly increased in number at the edge of the wound, first forming a layer to restore the ventricle wall, and then expanding this new layer of muscle.

Using techniques of cell biology, Keating’s team also showed that zebrafish with a genetic mutation affecting the enzyme mitotic checkpoint kinase (Mps1) no longer had rapid heart-cell formation and lost their ability to regenerate heart muscle. Instead, they had muscle scarring, as humans do. However, Keating emphasized this mutation is not necessarily the mechanism that inhibits cell proliferation in humans.

The next research steps will be to further investigate what genes are required for cardiomyocyte proliferation and heart regeneration in zebrafish, and to seek their counterparts in humans. Two major questions must then be answered. "Can you enhance cardiomyocyte proliferation in humans? That’s not known," Keating said. "And, if you enhance proliferation, will it induce cardiac regeneration?"

Many amphibians, such as newts, lizards, and salamanders, are also able to regenerate organs and tissues, whereas mammals, including humans, are not. But the zebrafish is an especially valuable model for studying the molecular mechanisms that trigger regeneration, because its genome shares many characteristics with the human genome. The small tropical fish also reproduces rapidly, facilitating genetic studies over multiple generations. A scientific push to sequence the zebrafish genome is under way at Children’s Hospital Boston and elsewhere.

"The field of regeneration has been of interest for thousands of years, but it hasn’t really entered the mainstream of molecular biology," said Keating. "The reason, in my opinion, is that the tools haven’t been there. We decided to create the field of zebrafish regeneration genetics."


Children’s Hospital Boston is home to the world’s largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults for over 100 years. More than 500 scientists, including seven members of the National Academy of Sciences, nine members of the Institute of Medicine and nine members of the Howard Hughes Medical Institute comprise Children’s research community. Founded in 1869 as a 20-bed hospital for children, Children’s Hospital Boston today is a 300-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. It is also the primary pediatric teaching affiliate of Harvard Medical School. For more information about the hospital visit: www.childrenshospital.org.

This research was funded by the Helen Hay Whitney Foundation and grants from the National Heart, Lung, and Blood Institute.


Elizabeth Andrews | EurekAlert!
Further information:
http://www.childrenshospital.org/

More articles from Health and Medicine:

nachricht Why might reading make myopic?
18.07.2018 | Universitätsklinikum Tübingen

nachricht Unique brain 'fingerprint' can predict drug effectiveness
11.07.2018 | McGill University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

Im Focus: Chemical reactions in the light of ultrashort X-ray pulses from free-electron lasers

Ultra-short, high-intensity X-ray flashes open the door to the foundations of chemical reactions. Free-electron lasers generate these kinds of pulses, but there is a catch: the pulses vary in duration and energy. An international research team has now presented a solution: Using a ring of 16 detectors and a circularly polarized laser beam, they can determine both factors with attosecond accuracy.

Free-electron lasers (FELs) generate extremely short and intense X-ray flashes. Researchers can use these flashes to resolve structures with diameters on the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

Global study of world's beaches shows threat to protected areas

19.07.2018 | Earth Sciences

New creepy, crawly search and rescue robot developed at Ben-Gurion U

19.07.2018 | Power and Electrical Engineering

Metal too 'gummy' to cut? Draw on it with a Sharpie or glue stick, science says

19.07.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>